Literature DB >> 23439705

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society.

Peer Carsten Tfelt-Hansen.   

Abstract

Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.

Entities:  

Mesh：

Year:  2013        PMID： 23439705     DOI： 10.1212/01.wnl.0000427909.23467.39

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Therapeutic antibodies against CGRP or its receptor.

Authors:  Marcelo E Bigal; Sarah Walter; Alan M Rapoport
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 2.  Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

Authors:  Marcelo E Bigal; Sarah Walter
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

3.  Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model.

Authors:  Tzu-Ting Liu; Andreia Morais; Cenk Ayata; Jiin-Cherng Yen; Tsubasa Takizawa; Inge Mulder; Bruce J Simon; Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2022-01-21       Impact factor: 7.277

4.  Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine.

Authors:  Hirohisa Okuma; Kazuyuki Iijima; Takashi Yasuda; Kentaro Tokuoka; Yasuhisa Kitagawa
Journal:  Springerplus       Date:  2013-10-29

Review 5.  [Formalized consensus: clinical practice recommendations for the management of the migraine in African adult patients].

Authors:  Mahmoud Ait Kaci Ahmed; Monia Haddad; Beugré Kouassi; Hamid Ouhabi; Alain Serrie
Journal:  Pan Afr Med J       Date:  2016-05-25

6.  The Effects of Exposure to Low Frequency Electromagnetic Fields in the Treatment of Migraine Headache: A Cohort Study.

Authors:  Seyed Ehsan Mohammadianinejad; Manuchehr Babaei; Pedram Nazari
Journal:  Electron Physician       Date:  2016-12-25

Review 7.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

8.  Revealing the Neural Mechanism Underlying the Effects of Acupuncture on Migraine: A Systematic Review.

Authors:  Lu Liu; Tian Tian; Xiang Li; Yanan Wang; Tao Xu; Xixiu Ni; Xiao Li; Zhenxi He; Shan Gao; Mingsheng Sun; Fanrong Liang; Ling Zhao
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

Review 9.  A Bibliometric Analysis of Research Trends of Acupuncture Therapy in the Treatment of Migraine from 2000 to 2020.

Authors:  Tingting Zhao; Jing Guo; Yafang Song; Hao Chen; Mengzhu Sun; Lu Chen; Hao Geng; Lixia Pei; Jianhua Sun
Journal:  J Pain Res       Date:  2021-05-25       Impact factor: 3.133

10.  Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.

Authors:  Charly Gaul; Hans-Christoph Diener; Ulrich Danesch
Journal:  J Headache Pain       Date:  2015-04-03       Impact factor: 7.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.